Target intelligence / Profile preview

Rhinovirus coat protein (capsid proteins VP1, VP2, VP3, VP4) (VP1, VP2, VP3, VP4)

Target
VP1, VP2, VP3, VP4
Molecular classification
Viral capsid protein, Other
01

Overview

The Rhinovirus coat protein forms the icosahedral capsid of human rhinoviruses (HRV), composed of 60 copies each of four proteins: VP1, VP2, VP3 (~30 kDa β-barrels on the surface), and VP4 (~7 kDa internal polypeptide interfacing with RNA). VP1 hosts a hydrophobic pocket beneath the canyon receptor-binding site and protrusions with immunogenic epitopes; VP2 and VP3 contribute to surface loops and stability around symmetry axes; VP4 aids RNA packaging and internal dynamics. These proteins enable cell attachment via ICAM-1 (major group) or LDL-receptor family (minor group) at the canyon or star domain, triggering uncoating in endosomes. In disease, HRV causes common colds and exacerbates asthma/COPD through airway infection, with >160 serotypes evading immunity via VP1-3 surface variation. Drugs target the VP1 pocket, displacing natural 'pocket factors' to lock the capsid and block replication, though few reached market due to resistance and specificity issues. Capsid dynamics, including flexible loops and N-termini, influence assembly, disassembly, and antiviral susceptibility.

Other names
HRV capsid proteinRhinovirus capsidViral coat proteinVP1-VP4
02

Mechanism of action

Bind hydrophobic pocket in VP1 to inhibit uncoating and replication; Block receptor attachment; Stabilize capsid against disassembly

03

Biological functions

Virus assemblyVirus entryReceptor bindingUncoatingRNA packaging
04

Disease associations

Infection
05

Safety considerations

Potential for antiviral resistance due to capsid dynamicsChallenges from antigenic variation in surface epitopes
06

Interacting drugs

WIN56291

1 more in the full profile.

Beyond the preview

Go deeper on Rhinovirus coat protein (capsid proteins VP1, VP2, VP3, VP4) (VP1, VP2, VP3, VP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhinovirus coat protein (capsid proteins VP1, VP2, VP3, VP4) (VP1, VP2, VP3, VP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call